Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 8, 2010

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Dulera New Drug Initial Review Require Prior Approval Prior Approval Required
Vimovo New Drug Initial Review Require Prior Approval Prior Approval Required
Bromday New Drug Initial Review Require Prior Approval Prior Approval Required
Creon DR New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Onglyza New Drug Appeal Remove Prior Approval Requirement Require Prior Approval
Adcirca New Drug Appeal Preferred with Prior Approval Required Preferred with Prior Approval Required